THE TECHNOLOGY
Non-invasive, easily accessible viral genetic testing for accurate detection of viral-induced cancer
THE CHALLENGE
Most patients diagnosed with NPC (nasopharyngeal cancer) have advanced stage cancer. Detection is evasive due to:
- The obscure location of the cancer
- Limited capability of standard medical equipment
- Difficulty recognizing small or sub-mucosal cancer visually or via endoscopy
Early NPC can be treated effectively with radiation.
Late-stage NPC requires a combination of radiation and chemotherapy, with higher treatment-related complications and reduced survival.
OUR SOLUTION
NP Screen offers the paradigm shift from effective treatment to early detection.
Early detection improves five-year survival rates for NPC from 30% to over 90%.
NP Screen enhances detection where endoscopy is uncertain or falsely negative.
THE TECHNOLOGY
The Collection Device
- NP Screen’s proprietary brush is designed to collect microscopic samples painlessly
- Targets deeper layers without discomfort
- Ideal for early detection of small or submucosal tumors that can be missed by endoscopy
The Preservation Solution
- NP Screen’s proprietary solution allows preservation of DNA samples at room temperature for long periods of time
- Addresses the challenges of safely transporting cellular samples from testing to analysis with simplified storage
- Is far superior to other means of preservation, including those used for blood tests, which may yield higher false-negative results due to DNA degradation
The Q-PCR Test
- Utilizes a highly accurate, semi-quantitative test using the latest Q-PCR (Quantitative Polymerase Chain Reaction) protocol
- NP Screen accurately detects minute quantity of EBV DNA from cellular samples
- Provides very high Positive and Negative Predictive Values (PPV and NPV) for detection of nasopharyngeal cancer